{"name":"Nevirapine","slug":"nevirapine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Viramune","Bi-rg-587","Nevirapine anhydrous","Viramune XR","Birg 0587","Nevirapine teva","Nevirapina","Nevirapine, anhydrous","Birg587","Birg-0587"],"brands":[],"scraped":true,"has_structure":true,"cid":4463,"classes":[],"families":[],"physical":[{"label":"Molecular mass","value":"266.30 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from pyridine and water","copyable":false},{"label":"Melting point","value":"196.06","copyable":false},{"label":"Solubility","value":"0.7046 mg/L","copyable":false},{"label":"Predicted LogP","value":"2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>O","copyable":true},{"label":"IUPAC name","value":"2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","copyable":true},{"label":"SMILES","value":"CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4","copyable":true},{"label":"InChI","value":"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)","copyable":true},{"label":"InChIKey","value":"NQDJXKOVJZTUJA-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"129618-40-2","copyable":true},{"label":"UNII","value":"99DK7FVK1H","copyable":true},{"label":"PubChem CID","value":"4463","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"45 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney: &lt;6% (Parent drug) , Bile duct &lt;5% (Parent drug)","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Nevirapine hemihydrate","name":"hemihydrate","slug":"nevirapine_hemihydrate","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"J","description":"Antiinfectives for systemic use"},{"code":"J05","description":"Antivirals for systemic use"},{"code":"J05A","description":"Direct acting antivirals"},{"code":"J05AG","description":"Non-nucleoside reverse transcriptase inhibitors"},{"code":"J05AG01","description":""},{"code":"J05AG01","description":"Nevirapine"}],"mesh":[{"name":"Reverse Transcriptase Inhibitors","id":"M0028255"},{"name":"Anti-HIV Agents","id":"M0028839"},{"name":"Cytochrome P-450 CYP3A Inducers","id":"M0590399"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["metabolism","inhibition","induction"],"partners":779,"contraindicated":4},{"target":"CYP2D6","mechanisms":["metabolism","inhibition","induction"],"partners":193,"contraindicated":0},{"target":"CYP2B6","mechanisms":["metabolism","induction","inhibition"],"partners":58,"contraindicated":0}],"mechanism":"Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.","side_effects":{"drug_id":4463,"drug_name":"nevirapine","url":"https://sideeffects.embl.de/drugs/4463/pt","atc_codes":["J05AG01"],"side_effects":[{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Liver function test abnormal","cui":"C0151766"},{"name":"Alanine aminotransferase increased","cui":"C0151905"},{"name":"Headache","cui":"C0018681"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Nausea","cui":"C0027497"},{"name":"Hepatotoxicity","cui":"C0235378"},{"name":"Myalgia","cui":"C0231528"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Drug eruption","cui":"C0011609"},{"name":"Blood pressure increased","cui":"C0497247"},{"name":"Blood phosphorus decreased","cui":"C0877517"},{"name":"Agranulocytosis","cui":"C0001824"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Toxic epidermal necrolysis","cui":"C0014518"},{"name":"Erythema multiforme","cui":"C0014742"},{"name":"Stevens-Johnson syndrome","cui":"C0038325"},{"name":"Anaphylactic shock","cui":"C0002792"},{"name":"Anaemia","cui":"C0002871"},{"name":"Angioedema","cui":"C0002994"},{"name":"Blister","cui":"C0005758"},{"name":"Dermatitis bullous","cui":"C0085932"},{"name":"Bullous eruption","cui":"C0235818"},{"name":"Conjunctivitis","cui":"C0009763"},{"name":"Oedema","cui":"C0013604"},{"name":"Eosinophilia","cui":"C0014457"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Hepatitis","cui":"C0019158"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Jaundice","cui":"C0022346"},{"name":"Neutropenia","cui":"C0027947"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Paraesthesia skin","cui":"C0235046"},{"name":"Rhabdomyolysis","cui":"C0035410"},{"name":"Mouth ulceration","cui":"C0149745"},{"name":"Urticaria","cui":"C0042109"},{"name":"Vomiting","cui":"C0042963"},{"name":"Hepatic failure","cui":"C0085605"},{"name":"Oral disorder","cui":"C0026636"},{"name":"Hepatitis cholestatic","cui":"C0149904"},{"name":"Hepatic necrosis","cui":"C0151798"},{"name":"Malaise","cui":"C0231218"},{"name":"Discomfort","cui":"C0234215"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Ill-defined disorder","cui":"C2047937"},{"name":"Pain","cui":"C0030193"},{"name":"Hepatitis fulminant","cui":"C0302809"},{"name":"Lymphadenopathy","cui":"C0497156"},{"name":"Face oedema","cui":"C0542571"},{"name":"Drug reaction with eosinophilia and systemic symptoms","cui":"C1142139"},{"name":"Drug interaction","cui":"C0687133"},{"name":"Somnolence","cui":"C2830004"},{"name":"Congenital anomaly","cui":"C0000768"},{"name":"Developmental delay","cui":"C0424605"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Autoimmune disorder","cui":"C0004364"},{"name":"Bone disorder","cui":"C0005940"},{"name":"Connective tissue disorder","cui":"C0009782"},{"name":"Dermatitis exfoliative","cui":"C0011606"},{"name":"Erythema nodosum","cui":"C0014743"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Basedow's disease","cui":"C0018213"},{"name":"Hepatitis toxic","cui":"C0019193"},{"name":"Hypercholesterolaemia","cui":"C0020443"},{"name":"Hyperglycaemia","cui":"C0020456"},{"name":"Hypertriglyceridaemia","cui":"C0020557"},{"name":"Blood triglycerides increased","cui":"C0853692"},{"name":"Breast enlargement","cui":"C2225524"},{"name":"Immune system disorder","cui":"C0021053"},{"name":"Inflammation","cui":"C0021368"},{"name":"Insulin resistance","cui":"C0021655"},{"name":"Lipodystrophy acquired","cui":"C0877192"},{"name":"Liver disorder","cui":"C0023895"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Foetor hepaticus","cui":"C0239571"},{"name":"Necrosis","cui":"C0027540"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Opportunistic infection","cui":"C0029118"},{"name":"Pancreatitis","cui":"C0030305"},{"name":"Neuropathy peripheral","cui":"C0031117"},{"name":"Pruritus","cui":"C0033774"},{"name":"Renal failure","cui":"C0035078"},{"name":"Thrombocytopenia","cui":"C0040034"},{"name":"Ulcer","cui":"C0041582"},{"name":"Erythema","cui":"C0041834"},{"name":"Gamma-glutamyltransferase increased","cui":"C0151662"},{"name":"Aspartate aminotransferase increased","cui":"C0151904"},{"name":"Liver injury","cui":"C0160390"},{"name":"Traumatic liver injury","cui":"C2242588"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Rash erythematous","cui":"C0234913"},{"name":"Hepatic enzyme increased","cui":"C0235996"},{"name":"Skin exfoliation","cui":"C0237849"},{"name":"Vertical infection transmission","cui":"C0242648"},{"name":"Hepatobiliary disease","cui":"C0267792"},{"name":"Hepatitis acute","cui":"C0267797"},{"name":"Rash maculo-papular","cui":"C0423791"},{"name":"Transaminases increased","cui":"C0438717"},{"name":"Lipohypertrophy","cui":"C1262113"},{"name":"Chronic hepatitis B","cui":"C0524909"},{"name":"Surgery","cui":"C0543467"},{"name":"Hyperlactacidaemia","cui":"C0795692"},{"name":"Fat redistribution","cui":"C0856151"},{"name":"Rash papular","cui":"C1519353"},{"name":"Hypertransaminasaemia","cui":"C2242708"}],"indications":[{"name":"Acquired immunodeficiency syndrome","cui":"C0001175"},{"name":"Hepatotoxicity","cui":"C0235378"},{"name":"Infection","cui":"C0009450"},{"name":"Rash","cui":"C0015230"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[3]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"European Union","status":"Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Nevirapine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4463"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q263713"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00238"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL57"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A63613"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=129618-40-2"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014383"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07263"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID7031797"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Nevirapine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/99DK7FVK1H"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4463/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4463, Nevirapine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/4463>https://pubchem.ncbi.nlm.nih.gov/compound/4463</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nevirapine. UNII: 99DK7FVK1H. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/99DK7FVK1H>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/99DK7FVK1H</a>","Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. Therapeutic Goods Administration (TGA). 21 June 2022. <a href='https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017'>https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:01:18","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 18:01:14","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 18:01:14","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:01:15","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:01:14","note":"hmdb.ca refused automated access to HMDB0014383"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:01:17","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:01:14","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:01:14","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 18:01:14","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:01:14","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:01:15","note":null}],"description":"Nevirapine is a  substance."}